Navigation Links
Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations
Date:5/13/2008

Andrew Raguskus to Serve as Senior Technology Advisor

SALT LAKE CITY, May 13 /PRNewswire-FirstCall/ -- The Board of Directors of Sonic Innovations, Inc. (Nasdaq: SNCI), a leading producer of advanced digital hearing aids, today announced that Andrew Raguskus has stepped down as Chairman of the Board. Mr. Raguskus will continue as a member of the Board of Directors and serve as its Senior Technology Advisor. As a result of Mr. Raguskus' announcement, the Board of Directors appointed CEO Sam Westover to serve as Chairman of the Board and Chief Executive Officer for the company.

James Callahan will continue to serve as Lead Independent Director for the Board of Directors. Mr. Callahan has been a director for the company since 2004 and was reelected for an additional three year term at this year's annual shareholders meeting. He is also a member of the Board's Audit and Compensation Committees.

In making his announcement, Mr. Raguskus stated, "When I was asked to serve as Chairman of the Board it was with the intention of giving Sam [Westover] time to focus his attention on the strategy and operations of the business. He has clearly set the company on the right path and, therefore, it is time for me to step aside and allow him to assume full leadership responsibility for the company."

"Andy has been a tremendous asset to this company and the Board and I have the utmost respect for his leadership and accomplishments," said Mr. Westover in response to his appointment as Chairman of the Board. "Sonic would not be celebrating its 10-year anniversary were it not for his commitment to developing and delivering the best hearing instruments. I am pleased that Andy has agreed to accept the role of Senior Technical Advisor. His knowledge and insight to the hearing aid industry will be invaluable as we continue to develop new products to meet the needs of our customers."

About Sonic Innovations

Sonic Innovations, Inc. is the largest, publicly traded U.S.-based hearing aid manufacturer. The company was founded with a mission to commercialize a unique digital signal processing platform for hearing aids. Sonic Innovations hearing aids were among the first of their kind clinically proven to increase speech understanding in noise for the hearing impaired. Sonic Innovations, headquartered in Salt Lake City, is listed on the NASDAQ Global Market System and can be found online at http://www.sonici.com.

This press release may contain "forward-looking statements" as defined under securities laws. Actual results may differ materially and adversely from those described herein depending on a number of factors including, but not limited to, the following risks: we face aggressive competition in our business; acquisitions could be difficult to integrate and disrupt our current business and therefore may harm our operating results; we may poorly operate newly acquired businesses; we may lose a large customer or suffer a reduction in orders from a large customer; we must have innovative, technologically superior products to compete effectively; our products, due to their complexity, may contain errors or defects that are only discovered after sales by our customers, thus harming our reputation and business; we may have issues with intellectual property; and we have important international operations, which expose us to a variety of risks including government reimbursement, that could impact sales and operating results. For additional information regarding the risks inherent in our business, please see "Factors That May Affect Future Performance" included in our Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.


'/>"/>
SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chrysler LLC Vice Chairman and President Jim Press and His Wife Suwichada Serve as Honorary Co-Chairs of Annual Juvenile Diabetes Research Foundation Promise Ball
2. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
3. End-stage dementia patients deserve the same access to palliative care as people with cancer
4. VA-DoD Program Serves Severely Disabled Combat Veterans
5. Warren F. Muth, MD, to Serve as President of Ohio State Medical Association
6. ACC Observes National Drinking Water Week
7. New Report: Increasing Ohios Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program
8. Old Orchard Introduces First Multi-Serve Vitamin Water, Sweetened with Agave Nectar and Real Fruit Juice
9. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
10. Cynthia Nixon to Serve as Ambassador for Susan G. Komen for the Cure(R)
11. Want docs to treat the underserved? Make sure they train at community health centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical ... neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse ... is a newly patented safety device secured by nasal surgeons onto the floor of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
Breaking Medicine Technology: